BHVN
Biohaven Ltd.
Key Financials
Operating Income
$-745378000
↑ 15.8%
Net Income
$-738822000
↑ 12.7%
EPS (Diluted)
$-6.86
↑ 26.1%
Total Liabilities
$399.4M
↑ 108.4%
Shareholders' Equity
$52.1M
↓ 87.7%
Total Assets
$451.4M
↓ 26.6%
Cash & Equivalents
$230.0M
↑ 132.0%
Operating Cash Flow
$-609438000.00
↓ 4.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 8-K | 5/5/2026 | View on SEC |
| 424B5 | 5/4/2026 | View on SEC |
| S-3ASR | 5/4/2026 | View on SEC |
| 10-Q | 5/4/2026 | View on SEC |
| 8-K | 5/4/2026 | View on SEC |
| 8-K | 5/4/2026 | View on SEC |
| 4 | 4/30/2026 | View on SEC |
| 4 | 4/30/2026 | View on SEC |
| 4 | 4/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BHVN |
| Company Name | Biohaven Ltd. |
| CIK | 1935979 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | D8 |
| Phone | 203-404-0410 |